StockData
Biodexa Pharmaceuticals Plc logo

Biodexa Pharmaceuticals Plc (BDRX) stock

BDRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 27, 2026Score 1/30
$2.24−0.16 (-6.67%)

Close on Nov 16, 2026Market cap $5.06MP/E –Yield –

Biodexa Pharmaceuticals EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

For fiscal 2025 it was -0.00 GBP. The highest annual figure on record is -0.00 GBP in fiscal 2025.

Annual eps

PeriodPeriod endValueChange
FY2025Dec 31, 2025-0.00 GBP–
FY2024Dec 31, 2024-0.00 GBP–
FY2023Dec 31, 2023-0.02 GBP–
FY2022Dec 31, 2022-1.55 GBP–
FY2017Dec 31, 2017-12400.00 GBP–
FY2016Dec 31, 2016-22400.00 GBP–
FY2015Dec 31, 2015-14400.00 GBP–

More Biodexa Pharmaceuticals figures

See a number that looks wrong?